rhodamine 123 has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schluesener, HJ | 2 |
2 other study(ies) available for rhodamine 123 and transforming growth factor beta
| Article | Year |
|---|---|
Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell lines.
Topics: Animals; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Bone Morphogenetic Proteins; Cell Line; Doxorubicin; Membrane Glycoproteins; Proteins; Rats; Rhodamine 123; Rhodamines; Transforming Growth Factor beta; Verapamil; Vincristine | 1991 |
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2.
Topics: Biological Transport; Drug Antagonism; Flow Cytometry; Fluorescent Dyes; Glioma; Humans; Rhodamine 123; Rhodamines; Transforming Growth Factor beta | 1991 |